Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Neisseria meningitidis serogroup W-135 polysaccharide is a group-specific capsular polysaccharide antigen derived from the bacterium Neisseria meningitidis, specifically from its W-135 serogroup. This molecule forms the basis for certain vaccines designed to prevent invasive diseases such as meningitis and septicemia caused by this pathogen.
Active immunization against Neisseria meningitidis serogroup W-135
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neisseria meningitidis serogroup W-135 polysaccharide (W-135 polysaccharide).